Literature DB >> 12652520

Regressive logistic and proportional hazards disease models for within-family analyses of measured genotypes, with application to a CYP17 polymorphism and breast cancer.

Jisheng S Cui1, Amanda B Spurdle, Melissa C Southey, Gillian S Dite, Deon J Venter, Margaret R E McCredie, Graham G Giles, Georgia Chenevix-Trench, John L Hopper.   

Abstract

Various statistical methods have been proposed to evaluate associations between measured genetic variants and disease, including some using family designs. For breast cancer and rare variants, we applied a modified segregation analysis method that uses the population cancer incidence and population-based case families in which a mutation is known to be segregating. Here we extend the method to a common polymorphism, and use a regressive logistic approach to model familial aggregation by conditioning each individual on their mother's breast cancer history. We considered three models: 1) class A regressive logistic model; 2) age-of-onset regressive logistic model; and 3) proportional hazards familial model. Maximum likelihood estimates were calculated using the software MENDEL. We applied these methods to data from the Australian Breast Cancer Family Study on the CYP17 5'UTR T-->C MspA1 polymorphism measured for 1,447 case probands, 787 controls, and 213 relatives of case probands found to have the CC genotype. Breast cancer data for first- and second-degree relatives of case probands were used. The three methods gave consistent estimates. The best-fitting model involved a recessive inheritance, with homozygotes being at an increased risk of 47% (95% CI, 28-68%). The cumulative risk of the disease up to age 70 years was estimated to be 10% or 22% for a CYP17 homozygote whose mother was unaffected or affected, respectively. This analytical approach is well-suited to the data that arise from population-based case-control-family studies, in which cases, controls and relatives are studied, and genotype is measured for some but not all subjects. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12652520     DOI: 10.1002/gepi.10222

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  8 in total

1.  Detecting pleiotropy and epistasis using variance components linkage analysis in jPAP.

Authors:  Sandra J Hasstedt; Alun Thomas
Journal:  Hum Hered       Date:  2011-12-23       Impact factor: 0.444

2.  Univariate and bivariate linkage analysis identifies pleiotropic loci underlying lipid levels and type 2 diabetes risk.

Authors:  Sandra J Hasstedt; Craig L Hanis; Steven C Elbein
Journal:  Ann Hum Genet       Date:  2010-07       Impact factor: 1.670

Review 3.  Gene--environment-wide association studies: emerging approaches.

Authors:  Duncan Thomas
Journal:  Nat Rev Genet       Date:  2010-04       Impact factor: 53.242

4.  Population-based, case-control-family design to investigate genetic and environmental influences on melanoma risk: Australian Melanoma Family Study.

Authors:  Anne E Cust; Helen Schmid; Judith A Maskiell; Jodie Jetann; Megan Ferguson; Elizabeth A Holland; Chantelle Agha-Hamilton; Mark A Jenkins; John Kelly; Richard F Kefford; Graham G Giles; Bruce K Armstrong; Joanne F Aitken; John L Hopper; Graham J Mann
Journal:  Am J Epidemiol       Date:  2009-11-03       Impact factor: 4.897

5.  Cell adhesion molecule 1: a novel risk factor for venous thrombosis.

Authors:  Sandra J Hasstedt; Irene D Bezemer; Peter W Callas; Carla Y Vossen; Winifred Trotman; Robert P Hebbel; Christine Demers; Frits R Rosendaal; Edwin G Bovill
Journal:  Blood       Date:  2009-07-30       Impact factor: 22.113

6.  Large numbers of individuals are required to classify and define risk for rare variants in known cancer risk genes.

Authors:  Brian H Shirts; Angela Jacobson; Gail P Jarvik; Brian L Browning
Journal:  Genet Med       Date:  2013-12-19       Impact factor: 8.822

7.  Pleiotropy of type 2 diabetes with obesity.

Authors:  Sandra J Hasstedt; Craig L Hanis; Swapan K Das; Steven C Elbein
Journal:  J Hum Genet       Date:  2011-04-28       Impact factor: 3.172

8.  The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer.

Authors:  Esther M John; John L Hopper; Jeanne C Beck; Julia A Knight; Susan L Neuhausen; Ruby T Senie; Argyrios Ziogas; Irene L Andrulis; Hoda Anton-Culver; Norman Boyd; Saundra S Buys; Mary B Daly; Frances P O'Malley; Regina M Santella; Melissa C Southey; Vickie L Venne; Deon J Venter; Dee W West; Alice S Whittemore; Daniela Seminara
Journal:  Breast Cancer Res       Date:  2004-05-19       Impact factor: 6.466

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.